Gara Jalqabaatti › Ependymoma
Qorannoo klinikaalii Ependymoma Ameerikaa Keessatti hirmaatuu
Qorannoo 15 Ependymoma f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
Naannoon
- CaliforniaQorannoo 3
- Distaarikii KoloombiyaaQorannoo 3
- MarylandQorannoo 4
- MassachusettsQorannoo 3
- PennsylvaniaQorannoo 3
- TexasQorannoo 3
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
Natural History Study of Patients With Neurofibromatosis Type 2
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 8 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT00598351Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 6 hanga 21 · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT07061626Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 19 · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT01356290HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Namoota walitti qabaa jiraSadarkaa 1
36 Months – 22 Years · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT03911388B7-H3.CD28Z.CART in CNS Neoplasms
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 2 hanga 21 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07390539Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT04374305PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 120 · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT06161519Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
Namoota walitti qabaa jira
12 Months – 39 Years · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT05057702Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 4 hanga 39 · Saalaa hunda · Haaromfame 20-Ado-2026 · NCT05278208Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT06193759ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 2 hanga 21 · Saalaa hunda · Haaromfame 11-Wax-2026 · NCT04732065LET Optimized IMPT in Treating Pediatric Patients With Ependymoma
Namoota walitti qabaa jiraSadarkaa 1
Hanga umuriin 22 · Saalaa hunda · Haaromfame 20-Cam-2026 · NCT03750513Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 26 · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT04185038Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 3 hanga 25 · Saalaa hunda · Haaromfame 09-Ama-2026 · NCT05106296Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Mud-2025 · NCT04541082Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.